Published on 18 November 2024
The NHS is launching a search for nearly 150,000 volunteers to take part in a series of research trials that could transform cancer treatment.
Three cancer projects have been selected as part of the NHS DigiTrials initiative, which aims to sign up tens of thousands of volunteers over the next 2 years to help improve the diagnosis and treatment of cancer patients.
Eligible people will start receiving letters and text messages from the NHS encouraging them to join the research projects from this month.
The biggest trial being supported, BEST4 Heartburn Health, requires 120,000 volunteers to help test a new screening technique for oesophageal cancer, which involves swallowing a compressed sponge on a string to extract cells from the food pipe.
A further 20,000 volunteers are needed for MyMelanoma, which will carry out the largest study of melanoma ever performed, to improve understanding of melanoma skin cancer and its treatment.
The PROTECT-C trial, funded by Yorkshire Cancer Research, will also recruit 5,000 women to take part in saliva-based genetic tests to check their genetic risk of developing ovarian, breast, endometrial and colorectal cancer.
The NHS DigiTrials recruitment service, which is managed by NHS England, identifies NHS patients who might be suitable for a certain trial and contacts them to see if they would like to take part.
An additional study being supported by DigiTrials, the Children’s Surgery Outcome Reporting project, will also focus on the care given to children who need complex surgery shortly after birth.
Vin Diwakar, National Director of Transformation at NHS England, said: “We’re pleased to be able to announce our support for these new research studies, 3 of which will help detect and treat cancer earlier and another which will improve the care of young children needing complex surgery – studies which could ultimately save lives.
“Clinical trials and other studies can often struggle to find and recruit eligible patients – particularly those facing the greatest inequalities – so the NHS’s DigiTrials service is able to invite people who are suitable for these research studies faster, fairly and at scale.
“The DigiTrials team will now start contacting people who may be eligible for the studies to see if they would like to take part, so I’d encourage anyone who receives a text message or letter from the NHS to consider signing up so that this ground-breaking research helps people like you and your communities.
“The trials will see the NHS working with leading academics across the country on research which could transform cancer treatment and benefit patients for decades to come.”